Methods for Subtyping Lymphoma Types by Means of Expression Profiling Read more about Methods for Subtyping Lymphoma Types by Means of Expression Profiling Ireland14803288.1Filed on 2014-11-05
Methods for Subtyping Lymphoma Types by Means of Expression Profiling Read more about Methods for Subtyping Lymphoma Types by Means of Expression Profiling United Kingdom14803288.1Filed on 2014-11-05
Methods for Subtyping Lymphoma Types by Means of Expression Profiling Read more about Methods for Subtyping Lymphoma Types by Means of Expression Profiling France14803288.1Filed on 2014-11-05
Methods for Subtyping Lymphoma Types by Means of Expression Profiling Read more about Methods for Subtyping Lymphoma Types by Means of Expression Profiling Spain14803288.1Filed on 2014-11-05
Methods for Subtyping Lymphoma Types by Means of Expression Profiling Read more about Methods for Subtyping Lymphoma Types by Means of Expression Profiling Germany14803288.1Filed on 2014-11-05
Methods for Subtyping Lymphoma Types by Means of Expression Profiling Read more about Methods for Subtyping Lymphoma Types by Means of Expression Profiling Switzerland14803288.1Filed on 2014-11-05
Affinity Matured M971 For CD22 Positive Cancer Therapeutics Development Read more about Affinity Matured M971 For CD22 Positive Cancer Therapeutics Development Patent Cooperation TreatyPCT/US2019/041401Filed on 2019-07-11
T Cell Receptors Recognizing HLA-A1-or HLA-CW7- Restricted Mage Read more about T Cell Receptors Recognizing HLA-A1-or HLA-CW7- Restricted Mage Hong Kong19129278.8Filed on 2019-09-06
ANTI-SLAMF7 CHIMERIC ANTIGEN RECEPTORS Read more about ANTI-SLAMF7 CHIMERIC ANTIGEN RECEPTORS Patent Cooperation TreatyPCT/US2019/039239Filed on 2019-06-26
INHIBITORS OF THE FARNESOID X RECEPTOR AND USES IN MEDICINE Read more about INHIBITORS OF THE FARNESOID X RECEPTOR AND USES IN MEDICINE China201910393592.0Filed on 2019-05-10